{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T10:32:46Z","timestamp":1791541966813,"version":"4.3.4"},"reference-count":118,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.neuropharm.2013.12.025","type":"journal-article","created":{"date-parts":[[2014,1,13]],"date-time":"2014-01-13T15:03:03Z","timestamp":1389625383000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["The genetics of cognitive epigenetics"],"prefix":"10.1016","volume":"80","author":[{"given":"Tjitske","family":"Kleefstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"van Bokhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.12.025_bib1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/496416a","article-title":"Mental health: on the spectrum","volume":"496","author":"Adam","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/- mice: a model for the cognitive deficit in Rubinstein\u2013Taybi syndrome and its amelioration","volume":"42","author":"Alarc\u00f3n","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.cell.2007.10.039","article-title":"New nomenclature for chromatin-modifying enzymes","volume":"131","author":"Allis","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders","isbn-type":"print","year":"2013","ISBN":"https:\/\/id.crossref.org\/isbn\/9780890425558"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib5","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00018-013-1265-9","article-title":"Mechanisms of mediator complex action in transcriptional activation","volume":"70","author":"Ansari","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molcel.2012.10.008","article-title":"Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer","volume":"49","author":"Asangani","year":"2013","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrg2987","article-title":"Regulation of X-chromosome inactivation by the X-inactivation centre","volume":"12","author":"Augui","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/383093","article-title":"Paradoxical NSD1 mutations in Beckwith\u2013Wiedemann syndrome and 11p15 anomalies in Sotos syndrome","volume":"74","author":"Baujat","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00439-013-1271-x","article-title":"Genetic syndromes caused by mutations in epigenetic genes","volume":"132","author":"Berdasco","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Bernstein","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajhg.2009.06.002","article-title":"Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations","volume":"85","author":"Boissel","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90400-6","article-title":"Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein","volume":"79","author":"Bourtchuladze","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-0004.2008.01060.x","article-title":"Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis","volume":"74","author":"Boyd","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/nar\/gkj437","article-title":"p66alpha and p66beta of the Mi-2\/NuRD complex mediate MBD2 and histone interaction","volume":"34","author":"Brackertz","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/humu.22141","article-title":"The KAT6B-related disorders genitopatellar syndrome and Ohdo\/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanisms","volume":"33","author":"Campeau","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ng.2646","article-title":"Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1","volume":"45","author":"Carvill","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib17","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1126\/science.1153252","article-title":"MeCP2, a key contributor to neurological disease, activates and represses transcription","volume":"320","author":"Chahrour","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.ejhg.5201595","article-title":"Genetics and pathophysiology of mental retardation","volume":"14","author":"Chelly","year":"2006","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nn.3412","article-title":"Exome sequencing to identify de novo mutations in sporadic ALS trios","volume":"16","author":"Chesi","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ajhg.2011.10.008","article-title":"Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say\u2013Barber\u2013Biesecker variant of Ohdo syndrome","volume":"89","author":"Clayton-Smith","year":"2011","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib21","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1042\/BST0380498","article-title":"Reversibility of functional deficits in experimental models of Rett syndrome","volume":"38","author":"Cobb","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.conb.2012.04.007","article-title":"A\u00a0genetic model for neurodevelopmental disease","volume":"22","author":"Coe","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib23","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/345718a0","article-title":"Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation","volume":"345","author":"Dash","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuron.2011.05.019","article-title":"Epigenetic mechanisms in cognition","volume":"70","author":"Day","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature11316","article-title":"HDAC8 mutations in Cornelia de Lange syndrome affect the cohesion acetylation cycle","volume":"489","author":"Deardorff","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1086\/511888","article-title":"Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of cornelia de Lange syndrome with predominant mental retardation","volume":"80","author":"Deardorff","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ajhg.2012.04.019","article-title":"RAD21 mutations cause a human cohesinopathy","volume":"90","author":"Deardorff","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gde.2012.11.011","article-title":"Chromatin organization: form to function","volume":"23","author":"de Graaf","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib29","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1206524","article-title":"Diagnostic exome sequencing in persons with severe intellectual disability","volume":"367","author":"de Ligt","year":"2012","journal-title":"New. Eng. J. Med."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4161\/epi.6.9.16069","article-title":"Substrate and product specificities of SET domain methyltransferases","volume":"6","author":"Del Rizzo","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/345647","article-title":"NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes","volume":"72","author":"Douglas","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0092-8674(95)90287-2","article-title":"Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome)","volume":"80","author":"Gibbons","year":"1995","journal-title":"Cell."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajhg.2011.11.018","article-title":"Mutations in EZH2 cause Weaver syndrome","volume":"90","author":"Gibson","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib34","doi-asserted-by":"crossref","first-page":"e61870","DOI":"10.1371\/journal.pone.0061870","article-title":"Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice","volume":"8","author":"Goldsworthy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib35","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.conb.2012.02.002","article-title":"Synaptopathies: diseases of the synaptome","volume":"22","author":"Grant","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajhg.2013.05.007","article-title":"De novo mutations in the genome organizer CTCF cause intellectual disability","volume":"93","author":"Gregor","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib37","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1101\/gad.1809209","article-title":"Epigenetic control of skull morphogenesis by histone deacetylase 8","volume":"15","author":"Haberland","year":"2009","journal-title":"Genes. Dev."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib38","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa0805392","article-title":"Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation","volume":"360","author":"Hamdan","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib39","doi-asserted-by":"crossref","first-page":"38998","DOI":"10.1074\/jbc.M307112200","article-title":"Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation","volume":"278","author":"Harada","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib40","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jmedgenet-2012-100921","article-title":"X-exome sequencing identifies a HDAC8 variant in a large pedigree with X-linked intellectual disability, truncal obesity, gynaecomastia, hypogonadism and unusual face","volume":"49","author":"Harakalova","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/cr.2011.32","article-title":"ATP-dependent chromatin remodeling: genetics, genomics and mechanisms","volume":"21","author":"Hargreaves","year":"2011","journal-title":"Cell. Res."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib42","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1101\/gad.201327.112","article-title":"Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3\/Mll4","volume":"26","author":"Herz","year":"2012","journal-title":"Genes. Dev."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib43","article-title":"Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities","author":"Hodge","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ng.868","article-title":"De novo nonsense mutations in ASXL1 cause Bohring\u2013Opitz syndrome","volume":"43","author":"Hoischen","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib45","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ajhg.2011.12.001","article-title":"Mutations in SRCAP, encoding SNF2-related CREBBP activator protein, cause Floating-Harbor syndrome","volume":"90","author":"Hood","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib46","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ccr.2012.10.024","article-title":"CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis","volume":"22","author":"Hu","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib47","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1101\/gad.14.14.1810","article-title":"BCoR, a novel corepressor involved in BCL-6 repression","volume":"14","author":"Huynh","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2012.04.009","article-title":"De novo gene disruptions in children on the autistic spectrum","volume":"74","author":"Iossifov","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ajhg.2012.06.008","article-title":"De novo mutations in MLL cause Wiedemann\u2013Steiner syndrome","volume":"91","author":"Jones","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.molcel.2005.11.012","article-title":"The human homolog of yeast BRE1 functions as a transcriptional coactivator through direct activator interactions","volume":"20","author":"Kim","year":"2005","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ajhg.2012.05.003","article-title":"Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability","volume":"91","author":"Kleefstra","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ng.830","article-title":"Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss","volume":"43","author":"Klein","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ng.2262","article-title":"Mutations in the chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome","volume":"44","author":"Koolen","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib53","doi-asserted-by":"crossref","first-page":"e1000569","DOI":"10.1371\/journal.pbio.1000569","article-title":"Epigenetic regulation of learning and memory by Drosophila EHMT\/G9a","volume":"9","author":"Kramer","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biocel.2008.08.009","article-title":"Genetic and epigenetic defects in mental retardation","volume":"41","author":"Kramer","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib55","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.1169786","article-title":"The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain","volume":"324","author":"Kriaucionis","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib56","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1101\/gr.136366.111","article-title":"Ubiquitous heterogeneity and asymmetry of the chromatin environment at regulatory elements","volume":"22","author":"Kundaje","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng863","article-title":"Haploinsufficiency of NSD1 causes Sotos syndrome","volume":"30","author":"Kurotaki","year":"2002","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.neuropharm.2013.12.025_bib58","doi-asserted-by":"crossref","first-page":"e11982","DOI":"10.1371\/journal.pone.0011982","article-title":"The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA","volume":"5","author":"Laget","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib59","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jmg.2004.029439","article-title":"Mutations in PHF8 are associated with X linked mental retardation and cleft lip\/cleft palate","volume":"42","author":"Laumonnier","year":"2005","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib60","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajhg.2011.11.021","article-title":"Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome","volume":"90","author":"Lederer","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib61","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1126\/science.1149042","article-title":"Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination","volume":"318","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/mrdd.10031","article-title":"The epidemiology of mental retardation: challenges and opportunities in the new millennium","volume":"8","author":"Leonard","year":"2002","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib63","doi-asserted-by":"crossref","first-page":"1237905","DOI":"10.1126\/science.1237905","article-title":"Global epigenomic reconfiguration during mammalian brain development","volume":"341","author":"Lister","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib64","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ng1040","article-title":"Mutations in PHF6 are associated with Borjeson\u2013Forssman\u2013Lehmann syndrome","volume":"32","author":"Lower","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.tins.2011.04.001","article-title":"Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes","volume":"34","author":"Mabb","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib66","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.febslet.2013.06.035","article-title":"Cohesin: functions beyond sister chromatid cohesion","volume":"587","author":"Mehta","year":"2013","journal-title":"FEBS. Lett."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib67","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1101\/gr.150078.112","article-title":"HCFC1 is a common component of active human CpG-island promoters and coincides with ZNF143, THAP11, YY1, and GABP transcription factor occupancy","volume":"23","author":"Michaud","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib68","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2012.11.015","article-title":"An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy","volume":"68","author":"Millan","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib69","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.2560","article-title":"Cortical DNA methylation maintains remote memory","volume":"13","author":"Miller","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib70","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ajmg.1320560125","article-title":"Tumors in Rubinstein\u2013Taybi syndrome","volume":"56","author":"Miller","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib71","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ng.2425","article-title":"CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development","volume":"44","author":"Mochida","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11011","article-title":"Patterns and rates of exonic de novo mutations in autism spectrum disorders","volume":"485","author":"Neale","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib73","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ng.646","article-title":"Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome","volume":"42","author":"Ng","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature08086","article-title":"A\u00a0histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf\u2013Hirschhorn syndrome","volume":"460","author":"Nimura","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib75","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1069861","article-title":"A\u00a0complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells","volume":"296","author":"Ogawa","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib76","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nature10989","article-title":"Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations","volume":"485","author":"O'Roak","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00708.x","article-title":"The modular nature of genetic diseases","volume":"71","author":"Oti","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1126\/science.337.6099.1159","article-title":"ENCODE project writes eulogy for junk DNA","volume":"337","author":"Pennisi","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/376348a0","article-title":"Rubinstein\u2013Taybi syndrome caused by mutations in the transcriptional co-activator CBP","volume":"376","author":"Petrij","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib80","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molcel.2013.04.018","article-title":"Chromatin insulators: linking genome organization to cellular function","volume":"50","author":"Phillips-Cremins","year":"2013","journal-title":"Mol. Cell."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib81","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.1091","article-title":"De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser\u2013Winter syndrome","volume":"44","author":"Rivi\u00e8re","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib83","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/429130","article-title":"Genetic heterogeneity in Rubinstein\u2013Taybi syndrome: mutations in both the CBP and EP300 genes cause disease","volume":"76","author":"Roelfsema","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrg3413","article-title":"From neural development to cognition: unexpected roles for chromatin","volume":"14","author":"Ronan","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib85","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ejhg.2009.175","article-title":"Identification and characterization of two novel JARID1C mutations: suggestion of an emerging genotype\u2013phenotype correlation","volume":"18","author":"Rujirabanjerd","year":"2010","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib86","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nrc3343","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"12","author":"Shih","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib87","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-biochem-051710-134100","article-title":"The COMPASS family of histone H3K4 methylases: mechanisms of regulation in development and disease pathogenesis","volume":"81","author":"Shilatifard","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib88","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.abb.2012.11.005","article-title":"Biotinylation of lysine 16 in histone H4 contributes toward nucleosome condensation","volume":"529","author":"Singh","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib89","series-title":"Cost of Illness in the Netherlands 2007: Trends in Healthcare Expenditure 1999\u20132010","author":"Slobbe","year":"2011"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib90","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrg3354","article-title":"DNA methylation: roles in mammalian development","volume":"14","author":"Smith","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib91","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/nbt.2398","article-title":"Mapping recently identified nucleotide variants in the genome and transcriptome","volume":"30","author":"Song","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib92","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1242\/jcs.114.13.2383","article-title":"CHMP1 is a novel nuclear matrix protein affecting chromatin structure and cell-cycle progression","volume":"114","author":"Stauffer","year":"2001","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib119","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/hmg\/7.7.1071","article-title":"WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma","volume":"7","author":"Stec","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib93","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib94","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","article-title":"Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification","volume":"146","author":"Tan","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib95","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.18632\/oncotarget.385","article-title":"Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height","volume":"2","author":"Tatton-Brown","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib96","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ajmg.c.31359","article-title":"The NSD1 and EZH2 overgrowth genes, similarities and differences","volume":"163C","author":"Tatton-Brown","year":"2013","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib97","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1021\/pr3004369","article-title":"PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex","volume":"11","author":"Todd","year":"2012","journal-title":"J.\u00a0Proteome Res."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib98","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2219","article-title":"Mutations affecting components of the SWI\/SNF complex cause Coffin\u2013Siris syndrome","volume":"44","author":"Tsurusaki","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-genet-110410-132512","article-title":"Genetic and epigenetic networks in intellectual disabilities","volume":"45","author":"van Bokhoven","year":"2011","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2010.03.010","article-title":"Disruption of the epigenetic code: an emerging mechanism in mental retardation","volume":"39","author":"van Bokhoven","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10048-011-0300-y","article-title":"Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri","volume":"13","author":"van den Munckhof","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib102","series-title":"GeneReviews\u2122 [Internet]","first-page":"1993","article-title":"MECP2 duplication syndrome","author":"Van Esch","year":"2008"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib104","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/ng1407","article-title":"Mutations in a new member of the chromodomain gene family cause CHARGE syndrome","volume":"36","author":"Vissers","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/521274","article-title":"Copy-number variations measured by single-nucleotide-polymorphism oligonucleotide arrays in patients with mental retardation","volume":"81","author":"Wagenstaller","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1139\/o11-033","article-title":"CTCF function is modulated by neighboring DNA binding factors","volume":"89","author":"Weth","year":"2011","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib107","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1093\/hmg\/ddt366","article-title":"A\u00a0comprehensive molecular study on Coffin\u2013Siris and Nicolaides\u2013Baraitser syndromes identifies a broad molecular and clinical spectrum converging on altered chromatin remodeling","volume":"22","author":"Wieczorek","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib108","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jmedgenet-2012-101490","article-title":"GATAD2B loss-of-function mutations cause a recognisable syndrome with intellectual disability and are associated with learning deficits and synaptic undergrowth in Drosophila","volume":"50","author":"Willemsen","year":"2013","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib109","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jmedgenet-2011-100294","article-title":"Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability","volume":"48","author":"Willemsen","year":"2011","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib110","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajhg.2010.07.011","article-title":"Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems","volume":"87","author":"Williams","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib111","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1093\/hmg\/dds035","article-title":"Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy","volume":"21","author":"Winkelmann","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib112","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1101\/gad.252103","article-title":"Human Sin3 deacetylase and trithorax-related Set1\/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1","volume":"17","author":"Wysocka","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib113","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/46214","article-title":"Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene","volume":"402","author":"Xu","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib114","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4161\/epi.24449","article-title":"Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats","volume":"8","author":"Xue","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib115","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature11401","article-title":"FTO genotype is associated with phenotypic variability of body mass index","volume":"490","author":"Yang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2013.12.025_bib116","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ajhg.2013.07.022","article-title":"An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1","volume":"93","author":"Yu","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib117","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nsmb.2470","article-title":"Regulation of nucleosome dynamics by histone modifications","volume":"20","author":"Zentner","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2013.12.025_bib118","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4161\/rna.24711","article-title":"Sprouts of RNA epigenetics: the discovery of mammalian RNA demethylases","volume":"10","author":"Zheng","year":"2013","journal-title":"RNA Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390814000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T05:58:39Z","timestamp":1648015119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390814000082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":118,"alternative-id":["S0028390814000082"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.12.025","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The genetics of cognitive epigenetics","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}